Defects in Hemostasis Flashcards

1
Q

VWD (types and dx)

A
  • COMMON; 1-3% US pop (often unnoticed in women w/ family hx immense menses)
  • VWF is coded on chromosome 12

TYPES

- 1 - low VWF so mild and late dx; responds to desmopressin (auto dom)
- 2- abnormal VWF; moderate and earlier dx; tx w/ VWF concentrate (auto dom)
    - 2A - loss of high wt VWF monomers
    - 2B - excessive platelet binding to VWF (thrombocytopenia); so only one w/ inc RCoF
    - 2M - dec VWF platelet binding
    - 2N - VWF does not carry FVIIIC
- 3- no VWF so severe and early dx; tx w/ VWF conc (auto recessive)
  • Dx - if dec APTT (b/c carrier for FVIII so now degraded - prolonged intrinsic path), low VIII, low RCoF, low VWF:Ag and prolonged closure time
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

RCoF

A
  • VWF activity is measured by RCoF or the amount of ristocetin it binds
  • Larger molecule = more binding sites = inc RCoF = greater chance microthrombus
  • Dec RCoF can mean more ADAMTS-13 or plasmin activity, inc binding of platelets so restocetin cannot bind, dec synthesis or release of VWF
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Normal Role of VWF

A
  • VWF is made by endo cells then stored in Weibel-Palade bodies and alpha granules of platelets
  • Acts as carrier for FVIII until Xa cleaves it from VWF to be used in intrinsic path
  • Released into plasma as large molecule then broken up by ADAMTS-13 enzyme (defective in TTP)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Hemophilia

A
  • Hemophilia A - FVIII def
  • Hemophilia B - FIX def
  • Both X-linked
  • Same presentation - bleeding w/ circumcision in baby boy; bleed into joints, muscles, body cavities, CNS hemorrhages, hematomas
  • Classic - teen male athlete w/ mult “pulled muscles that won’t heal” - actually muscle hematomas
  • Degeneration of synovial lining –> crippling OA
  • Tx - recombinant factors (worry about formation of inhibitors - T cell immune response against infused factors)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

FV Leiden Mutation

A

FV lacks protein C cleavage sites so resistant to breakdown of FVa –> inc venous thrombosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Vit K Def (causes and tx)

A
  • Fat-soluble; needed for activation of 2, 7, 9, 10, protein S and protein C
  • Causes of Deficiency
    • Diet
    • Hemorrhagic Disease of Newborn - lack of gut bacteria - bleed
    • Antibiotics - destroy gut flora that produce Vit K
    • Poor GI absorption - obstructive jaundice (no bile salts) or diarrhea/sprue
    • Inhibit synthesis - Warfarin, pesticides
  • Tx - oral or subQ vit K; Kcentra IV if urgent (all Vit K factors + small amount of heparin); use profilin + recombinant FVII if past HIT
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

How do you screen for Vit K def?

A
  • Screen w/ PT b/c FVII has shortest half life (7 hrs) - later both PT and APTT long
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What are the half-lives of all Vit K dep factors?

A
  • VII - 6 hrs
  • IX - 24 hrs
  • X - 40 hrs
  • II - 60 hrs
  • Protein C and S - < 6 hrs
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Liver Disease and Coagulation

A
  • Causes dec in synthesis and clearance of factors
  • Dec synthesis of coag factors (except VIII - made elsewhere)
  • Dec degradation of activated factors - DIC/fibrinolysis
  • Synthesis of abnormal factors - dysfibrinogen (takes longer to form clot and friable clot/susceptible to lysis - prolonged TT and RT)
  • Platelet Sequestration - thrombocytopenia
  • Tx - replace factors w/ fresh frozen plasma, transfuse platelets if thrombocytopenia, if fibrinolysis then use fibrinolytic inhibitors (aminocaproic acid and tranexamic acid)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

DIC

A
  • Excess thrombin generation –> small vessel thrombosis and bleeding; associated w/ consumption of factors, thrombocytopenia, platelet dysfunction, inc fibrinolysis
  • Both primary mucosal bleeding and secondary deeper bleeding is seen
  • See antithrombin activation –> depletion (anti-thrombin becomes overwhelmed by excess thrombin)
  • Fibrinogen –> FDP, FM, FSP which then polymerize –> insoluble fibrin –> creates narrow vessels –> RBC fragments/Burr cells/ schistocytes AND end-organ damage
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

DIC Dx

A

(3/6)

- 1- prolonged PT and/or APTT
- 2- dec platelets
- 3- dec fibrinogen
- 4- Inc fibrin split products
- 5- Dec antithrombin
- 6- RBC fragmentation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

5 Poss Causes of DIC

A
  • Infection (endotoxin)
  • Tissue injury from trauma, surgery, burns (TF)
  • OB complications - amniotic fluid embolus or abruptio placenta
  • Malignancy -prostate (activates FX), adenocarcinoma (activates trypsin) or promyelocytic leukemia (pro-coagulant material)
  • Liver disease - activated coagulation factors not cleared
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

DIC Tx

A

Tx - treat underlying cause + transfusion/replacement of missing elements in meantime

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Specific Inhibitors v Blocking Inhibitors

A

Specific Inhibitors (RARE)

  • Immune inhibition of coagulation factor (auto-immune or allo-immune from transfused factor)
  • Bleeding tendency
  • Symptoms = severe post-partum bleeding, bleeding in elderly w/o hx, bleeding in hemophilia despite FVIII

Blocking Inhibitors (lupus anti-coagulants)
-Inhibit coagulation REACTIONS (affect mult factors; directed at phospholipids)
-Thrombotic tendency
MORE COMMON (in 5% SLE pts)
-Symptoms = recurrent pregnancy loss, stroke at early age, thrombosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Examples of Specific Inhibitors

A

Anti-VIII - preg and Hemophilia A
Anti-X - amyloidosis
Anti - XIII - isoniazid
Anti-VWF - thryoid disease, lymphoma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Examples of Blocking Inhibitors

A

SLE
Malignancy
Drugs - procainamide, PCN, phenytoin, quinidine, hydralazine, propanolol

17
Q

Mixing Studies

A
  • mix pt plasma w/ normal plasma then perform PT and APTT

Correction - deficiency in inhibitor (works once 50%)

No correction - specific or blocking inhibitor; factors still attacked by antibodies

18
Q

Specific Hypercoaguable States

A
  • Anti-thrombin Def (liver disease, DIC, post-op, sepsis, nephrotic loss in urine, newborn, heparin use, acute thrombosis)
  • Protein C Def (liver, DIC, acute thrombosis, newborns has dec prod, Warfarin, Vit K def, post-op, resp distress)
  • Protein S Def (liver disease, preg/OC - inc bound to C4b, Warfarin, Vit K def)
  • Factor V Leiden Mutation
  • Prothrombin Gene Variant
    • Factor II G20210A mutation (base pair substitution of FII gene) –> inc levels of FII
19
Q

14 Secondary Hypercoagulable States

A
  • Sickle Cell
  • Myeloproliferative Neoplasms - make more RBCs and extra-medullary hematopoiesis
  • HITT
  • Nephrotic Syndrome - due to urinary loss of anti-thrombin
  • Paroxysmal Nocturnal Hemoglobinuria
  • Stasis - cast, long trips, post-operation or trauma
  • Artificial surfaces - catheter, heart valves
  • Prothrombin-Complex Concentrate administration
  • Pregnancy - esp 6 wks postpartum
  • Oral contraceptives/ estrogen
  • Malignancy - highest association is mucinous adenocarcinoma
  • Vasculitis/arteritis
  • Varicella-related autoimmune Protein S def
  • Lupus anti-coagulant (anti-phospholipoprotein antibodies)
    • Drugs - procainamide, hydralazine, phenothiazines, Haldol, primidone, ethosuximide, carbamazeponie, quinidine, alpha-interferon, impure cocaine, PCN (kids only)
    • Inc risk of LACs if HIV/AIDs, RA, elderly